Skip to main content
. 2022 Mar 3;12:800442. doi: 10.3389/fmicb.2021.800442

Figure 6.

Figure 6

Viability of PA-R16SCF and clinically multidrug-resistant P. aeruginosa in the presence of glucose plus antibiotics. (A) Percent survival of PA-R16SCF in the presence of the indicated antibiotics. (B) Percent survival of PA-R16SCF in the presence of the indicated concentrations of glucose plus amikacin. (C) Percent survival of PA-R16SCF in the presence of the indicated concentrations of amikacin plus glucose. (D) Percent survival of PA-R16SCF in the indicated incubation periods and in the presence of amikacin plus glucose. (E) Percent survival of clinically multidrug-resistant P. aeruginosa in the presence of glucose and amikacin. Results are displayed as mean ± SEM and three biological repeats are performed. Significant differences are identified **p < 0.01.